US 9574012
AGR2 blocking antibody and use thereof
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 9574012 (AGR2 blocking antibody and use thereof) held by Sanofi (China) Investment Co., Ltd. Shanghai Branch expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sanofi (China) Investment Co., Ltd. Shanghai Branch
- Grant date
- Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P